Extracted from this filing and checked against the source text.
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.9
PhenomeX Inc. incurred term loan of $70 million with East West Bank.
- Instrument
- term loan
- Principal
- $70 million
- Counterparty
- East West Bank
- Event
- incurrence
Exact text from the filing
On March 21, 2023, PhenomeX entered into a Second Amended and Restated Loan and Security Agreement (the “ PhenomeX Credit Agreement ”) with East West Bank, a California banking corporation (“ East West Bank ”), as lender, and the other parties thereto, which amends and restates that certain Amended and Restated Loan and Security Agreement, dated as of June 30, 2022 (the “ Existing Berkeley Lights Credit Agreement ”), to (i) continue certain existing term loan indebtedness under the Existing Berkeley Lights Credit Agreement, (ii) increase the term loan under the Existing Berkeley Lights Credit Agreement by $50 million, such that the aggregate outstanding principal amount of the term loan thereunder is $70 million
View on SEC.gov
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
PhenomeX Inc.: Amended and restated bylaws solely to reflect the name change to PhenomeX Inc (effective 2023-03-21).
- Change
- bylaw amendment
- Effective
- 2023-03-21
Exact text from the filing
In connection with the Name Change, the Company’s Amended and Restated Bylaws were amended and restated (the “ A&R Bylaws ”), effective on the Closing Date, solely to reflect the Name Change.
View on SEC.gov
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
PhenomeX Inc.: Amended and Restated Certificate of Incorporation to change company name from Berkeley Lights, Inc. to PhenomeX Inc (effective 2023-03-21).
- Change
- charter amendment
- Effective
- 2023-03-21
Exact text from the filing
On the Closing Date, Berkeley Lights filed a Certificate of Amendment (the “ Certificate of Amendment ”) to its Amended and Restated Certificate of Incorporation. The Certificate of Amendment changes the Company’s name to “PhenomeX Inc.” (the “ Name Change ”).
View on SEC.gov
M&A Transactions
SEC 8-K Item 2.01/5.01
confidence 1.0
PhenomeX Inc. completed an acquisition involving IsoPlexis Corporation for 0.6120 shares of PhenomeX Common Stock per share of IsoPlexis Common Stock, plus cash in lieu of fractional shares (closed 2023-03-21).
- Action
- acquisition
- Counterparty
- IsoPlexis Corporation
- Consideration
- 0.6120 shares of PhenomeX Common Stock per share of IsoPlexis Common Stock, plus cash in lieu of fractional shares
- Closing
- 2023-03-21
Exact text from the filing
to Berkeley Lights) (other than Merger Sub and unless held in a fiduciary, representative or other capacity on behalf of other persons)) was converted into the right to receive 0.6120 fully paid and nonassessable shares (the “ Exchange Ratio ”) of PhenomeX Common Stock (the “ Merger Consideration ”), together with cash in lieu of fractional shares of PhenomeX
View on SEC.gov